Rafferty Asset Management, LLC Amgen Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 140,221 shares of AMGN stock, worth $41.3 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

140,221

Previous 160,737 12.76%

Holding current value

$41.3 Million

Previous $50.2 Million 10.04%

% of portfolio

0.16%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $6.35 Million - $6.92 Million	-20,516 Reduced 12.76%	140,221 $45.2 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $6.76 Million - $8.21 Million	25,712 Added 19.04%	160,737 $50.2 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $2.12 Million - $2.56 Million	7,896 Added 6.21%	135,025 $38.4 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.2 Million - $1.35 Million	4,684 Added 3.83%	127,129 $36.6 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $371,923 - $461,753	1,701 Added 1.41%	122,445 $32.9 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $4.37 Million - $5.17 Million	20,388 Added 20.32%	120,744 $26.8 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $2.01 Million - $2.46 Million	8,923 Added 9.76%	100,356 $24.3 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $1.31 Million - $1.67 Million	5,733 Added 6.69%	91,433 $24 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $6.6 Million - $7.44 Million	29,382 Added 52.17%	85,700 $19.3 Million
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $2.83 Million - $3.14 Million	-12,247 Reduced 17.86%	56,318 $13.7 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $1.34 Million - $1.48 Million	6,104 Added 9.77%	68,565 $16.6 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $2.11 Million - $2.41 Million	10,585 Added 20.4%	62,461 $14.1 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $2.77 Million - $3.24 Million	13,043 Added 33.59%	51,876 $11 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $662,432 - $734,921	-2,836 Reduced 6.81%	38,833 $9.47 Million
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $1.99 Million - $2.32 Million	8,970 Added 27.43%	41,669 $10.4 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $14,281 - $17,006	-66 Reduced 0.2%	32,699 $7.52 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $2.61 Million - $2.9 Million	-11,130 Reduced 25.36%	32,765 $8.33 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $4.88 Million - $5.98 Million	24,649 Added 128.07%	43,895 $10.4 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $4.23 Million - $5.61 Million	-23,225 Reduced 54.68%	19,246 $3.9 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $2.86 Million - $3.67 Million	-15,106 Reduced 26.24%	42,471 $10.2 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $2.36 Million - $2.83 Million	13,575 Added 30.85%	57,577 $11.1 Million
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $701,140 - $821,894	4,206 Added 10.57%	44,002 $8.11 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $5.57 Million - $6.28 Million	30,791 Added 341.93%	39,796 $7.56 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $302,923 - $353,608	-1,698 Reduced 15.86%	9,005 $1.75 Million
Q3 2018 Nov 09, 2018	BUY	$185.29 - $208.89 $128,035 - $144,342	691 Added 6.9%	10,703 $2.22 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $100,792 - $113,211	607 Added 6.45%	10,012 $1.85 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $160,450 - $187,506	947 Added 11.2%	9,405 $1.6 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $19,917 - $22,253	118 Added 1.41%	8,458 $1.47 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.4 Million - $1.59 Million	8,340	8,340 $1.56 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Amgen Inc Transaction History